# 68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients

> **NCT03164837** · PHASE1 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 68Ga-NOTA-RM26

## Key facts

- **NCT ID:** NCT03164837
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03164837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03164837, "68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03164837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*